Skip to content

Clinical trials

Respiratory Syncytial Virus Infections trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Country / region: Canada Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20101
20131
20141
20151
20161
20171
20181
20195
20201
20217
20233
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Active, not recruiting4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline16
AstraZeneca2
MedImmune LLC2
Merck Sharp & Dohme LLC2
Alios Biopharma Inc.1
Alnylam Pharmaceuticals1
Enanta Pharmaceuticals, Inc1
Janssen Research & Development, LLC1
Regeneron Pharmaceuticals1
Sunnybrook Health Sciences Centre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections30
COVID-191
Infections1
Influenza, Human1
Whooping Cough1

Trials

Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.